Enhancing Breakthrough Medical Device Access: E...

By HEOR Staff Writer

April 28, 2026

The European Medicines Agency (EMA) has launched a pilot programme to deliver breakthrough medical device access for high-risk technologies that address unmet medical needs. Starting 28 April 2026, the initiative offers enhanced scientific advice ...
Medical Device Innovation South Africa: Breaking Down Systemic Barriers
Expanding Access to Hormonal IUDs in South Africa through Generic Innovation
Regulatory Divergence in PSMA Targeted Therapy: Implications for European Mar...
PIONEER TEENS Trial Reveals Oral Semaglutide Diabetes Breakthrough for Pediat...
Terminal Complement Inhibition: Promising Results in IgAN from the I CAN Trial
Advancing Multicenter AKI Prediction: Benefits of Collaborative Models Over L...
Advancements in Rare Disease Therapies: CHMP’s April 2026 Insights and ...
Europe Pharmaceutical Access at a Critical Crossroads Amid U.S. Pricing Policies
Economic Impact of Fragmented Care: Tackling Obesity, Diabetes, and Cardiovas...
Zanidatamab Biliary Cancer Therapy: Advancing Targeted Treatment for HER2-Pos...
Advancements in HIV Two-Drug Regimen: FDA Approves IDVYNSO for Virologically ...
Progress and Challenges in the FDA Accelerated Approval Pathway: A Policy Roa...